HomeCompareMDCLF vs MO

MDCLF vs MO: Dividend Comparison 2026

MDCLF yields 5.82% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $48.4K in total portfolio value· pulled ahead in Year 6
10 years
MDCLF
MDCLF
● Live price
5.82%
Share price
$34.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$842.73
Full MDCLF calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — MDCLF vs MO

📍 MO pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDCLFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDCLF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDCLF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDCLF
Annual income on $10K today (after 15% tax)
$494.33/yr
After 10yr DRIP, annual income (after tax)
$716.32/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $23,906.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDCLF + MO for your $10,000?

MDCLF: 50%MO: 50%
100% MO50/50100% MDCLF
Portfolio after 10yr
$53.5K
Annual income
$14,905.63/yr
Blended yield
27.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

MDCLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
5.5
Piotroski
5/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDCLF buys
0
MO buys
0
No recent congressional trades found for MDCLF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDCLFMO
Forward yield5.82%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$29.3K$77.7K
Annual income after 10y$842.73$28,968.54
Total dividends collected$7.2K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: MDCLF vs MO ($10,000, DRIP)

YearMDCLF PortfolioMDCLF Income/yrMO PortfolioMO Income/yrGap
1$11,282$581.56$10,558$768.31+$724.00MDCLF
2$12,684$613.17$11,352$1,015.87+$1.3KMDCLF
3$14,217$644.32$12,482$1,367.86+$1.7KMDCLF
4$15,887$674.91$14,103$1,883.39+$1.8KMDCLF
5$17,704$704.85$16,472$2,664.91+$1.2KMDCLF
6← crossover$19,677$734.08$20,024$3,897.79$347.00MO
7$21,817$762.53$25,537$5,933.74$3.7KMO
8$24,134$790.14$34,478$9,476.77$10.3KMO
9$26,641$816.89$49,776$16,022.63$23.1KMO
10$29,348$842.73$77,699$28,968.54$48.4KMO

MDCLF vs MO: Complete Analysis 2026

MDCLFStock

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.

Full MDCLF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this MDCLF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDCLF vs SCHDMDCLF vs JEPIMDCLF vs OMDCLF vs KOMDCLF vs MAINMDCLF vs PMMDCLF vs BTIMDCLF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.